Managing localized prostate cancer in the era of prostate‐specific antigen screening

E-ISSN： 1097-0142|119|22|3906-3909

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.22, 2013-11, pp. : 3906-3909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictors of Delayed Therapy after Expectant Management for Localized Prostate Cancer in the Era of Prostate-Specific Antigen

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 194-202

Karger

Access to resources Recommend Favorite

Prostate Cancer Screening with Prostate-Specific Antigen in Hemodialysis Patients

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 334-337

Karger

Access to resources Recommend Favorite

Prostate‐specific antigen‐based prostate cancer screening: Past and future

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 524-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostate cancer screening with prostate‐specific antigen: Where are we going?

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 453-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2795-2802

John Wiley & Sons Inc

Access to resources Recommend Favorite